Adenocarcinoma Of Esophagus Recruiting Phase 2 Trials for Avelumab (DB11945)

Also known as: Adenocarcinoma of Oesophagus / Oesophageal Adenocarcinoma / Adenocarcinoma, Esophageal / Esophageal Adenocarcinomas / Esophageal Adenocarcinoma / Oesophageal adenocarcinoma NOS

IndicationStatusPhase
DBCOND0067383 (Adenocarcinoma Of Esophagus)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03399071Study Title: Peri-operative Immuno-Chemotherapy in Operable Oesophageal and Gastric CancerTreatment
NCT03783936Trial of mFOLFOX6 + Trastuzumab + Avelumab in Gastric and Esophageal AdenocarcinomasTreatment
NCT03288350mDCF + Avelumab in Resectable Esophago-gastric Adenocarcinoma (EGA)Treatment